BioAcyl Corp
BioAcyl Corp |
|
 |
 |
 |
|
Tang, Q., Xue, N., Ding, X., Tsai, K. H. -Y., Hew, J. J., & Jiang, R., et al. (2023). Role of wound microbiome, strategies of microbiota delivery system and clinical management. Advanced Drug Delivery Reviews, 192, 114671. Added by: Dr. Enrique Feoli (16/02/2023, 17:43) Last edited by: Dr. Enrique Feoli (16/02/2023, 18:30) |
 |
| Resource type: Journal Article DOI: https://doi.org/10.1016/j.addr.2022.114671 ID no. (ISBN etc.): 0169-409X BibTeX citation key: Tang2023 View all bibliographic details  |
Categories: BioAcyl Corp, BioAcyl Corp Subcategories: Microbiota in wound healing, Wound Healing Creators: Chen, Cheng, Cheng, Ding, Ding, Hew, Huang, Jiang, Tang, Tsai, Wang, Xue Collection: Advanced Drug Delivery Reviews |
Views: 1/164
|
| Abstract |
|
Delayed wound healing is one of the most global public health threats affecting nearly 100 million people each year, particularly the chronic wounds. Many confounding factors such as aging, diabetic disease, medication, peripheral neuropathy, immunocompromises or arterial and venous insufficiency hyperglycaemia are considered to inhibit wound healing. Therapeutic approaches for slow wound healing include anti-infection, debridement and the use of various wound dressings. However, the current clinical outcomes are still unsatisfied. In this review, we discuss the role of skin and wound commensal microbiota in the different healing stages, including inflammation, cell proliferation, re-epithelialization and remodelling phase, followed by multiple immune cell responses to commensal microbiota. Current clinical management in treating surgical wounds and chronic wounds was also reviewed together with potential controlled delivery systems which may be utilized in the future for the topical administration of probiotics and microbiomes. This review aims to introduce advances, novel strategies, and pioneer ideas in regulating the wound microbiome and the design of controlled delivery systems.
|